Tag: SIDE

Leave a Reply

Your email address will not be published. Required fields are marked *

Immune Checkpoint Inhibitor Therapy Tied to Cardiac Event Risk

Increased risks persist beyond six months for patients with lung cancer receiving PD1i and with malignant melanoma receiving CTLA-4i<strong></strong>